The Collaborative Islet Transplantation Registry Program
Page 2

The program also seeks to deeply comprehend the factors that contribute to the success and/or failure of islet transplantation protocols and more importantly, to develop approaches for continued improvements that could essentially result in sustained graft function and therapeutic durability.

The National Institutes of Health and the National Institute of Diabetes and Digestive and Kidney Diseases are willing to administer funds in the amount $2,650,000 to support the initiatives of the program.

The institutions and organizations who will be considered eligible to participate in this program are the following:

a) State Governments

b) County Governments

c) City or Township Govenments

d) Special District Governments

e) Independent School Districts

f) Public and State Controlled Institutions of Higher Education

g) Native American Tribal Governments

h) Public Housing Authorities/Indian Housing Authorities

i) Native American Tribal Organizations (other than Federally recognized tribal governments)

j) Nonprofit Organizations

k) Private Institutions of Higher Education

l) For-profit organizations other than small businesses

m) Small Businesses

The United States Department of Health and Human Services, the mother agency funding the The Collaborative Islet Transplantation Registry Program, is the country's leading program that's constantly working towards protecting the health of all Americans and providing fundamental human services to all.

The Collaborative Islet Transplantation Registry Program
  Back to Page 1

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Critical Congenital Heart Disease Newborn Screening Demonstration Program
The Health Resources and Services Administration has recently constituted the Critical Congenital Heart Disease (CCHD) Newborn Screening Demonstration Program in order to support and encourage the development, dissemination, and validation of screening protocols and newborn screening infrastructure for point of care screenings that are specific to Critical Congenital Heart Diseases.

---

Clinical Trials for Organ Transplantation in Children Program
The National Insitutes of Health has formed a partnership with the National Institute of Allergy and Infectious Diseases (NIAID) to establish the Clinical Trials for Organ Transplantation in Children Program wherein both agencies intend to support a group of investigators in their quest of conducting clinical trials regarding pediatric solid organ transplant recipients.

---

2012 Tuberous Sclerosis Complex Clinical Trial Award Program
In line with this mission, the United States Department of Defense has recently established the 2012 Tuberous Sclerosis Complex Clinical Trial Award Program in an attempt to financially support the studies regarding the promotion innovative research focused on decreasing the clinical impact of tuberous sclerosis complex (TSC).

---

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---